论文部分内容阅读
目的:了解手术及输血前患者肝炎感染情况,探讨医源性肝炎传染的风险,避免可能发生的医疗纠纷。方法:对6147例手术及输血前患者采用ELISA法检测HBsAg、HBsAb、HBeAg、HBeAb、HBcAb、抗-HCV;采用速率法测ALT。结果:患者血液异常的总阳性率为23.6%,其中HBsAg阳性867人(阳性率14.1%)、HBcAb阳性287人(阳性率4.52%)、抗-HCV阳性88人(阳性率1.43%)、ALT阳性573人(阳性率9.32%)。结论:对患者进行手术及输血前肝炎指标检测有利于患者的治疗及医务人员的自我保护,还可减少或避免因手术及输血而引起的医疗纠纷及防止医院感染。
OBJECTIVE: To understand the hepatitis infection in patients before surgery and transfusion, to explore the risk of iatrogenic hepatitis infection and to avoid possible medical disputes. Methods: 6147 cases of preoperative and transfusion patients were detected by ELISA ELISA HBsAg, HBeAb, HBeAg, HBeAb, HBcAb, anti-HCV; using rate method for the determination of ALT. Results: The total positive rate of blood abnormalities in patients was 23.6%, of which 867 were HBsAg positive (positive rate was 14.1%), HBcAb positive was 287 (positive rate was 4.52%), anti-HCV positive was 88 (positive rate was 1.43%), ALT Positive 573 people (positive rate 9.32%). Conclusion: The detection of hepatitis before surgery and blood transfusion is beneficial to the treatment of patients and self-protection of medical personnel. It can also reduce or avoid medical disputes caused by surgery and blood transfusion and prevent nosocomial infections.